Zobrazeno 1 - 10
of 119
pro vyhledávání: '"E, Ripe"'
Publikováno v:
European Respiratory Journal. 3:46-54
Eight patients with chronic obstructive lung disease (COLD) and pulmonary hypertension were given an infusion of a calcium antagonist, felodipine, during ongoing, long-term oxygen treatment (LTOT). The effects on central haemodynamics and ventilation
Publikováno v:
American Journal of Roentgenology. 135:703-712
The clinical, radiographic, and histopathologic characteristics of pulmonary muscular hyperplasia were analyzed in 13 patients who were seen over a 13 year period. The average follow-up period was 7.2 years (range, 1-13). Eight patients initially dem
Publikováno v:
European Respiratory Journal. 1:262-268
Eleven patients, with advanced chronic obstructive lung disease (COLD), received an infusion of the calcium antagonist felodipine at a rate of 0.9 mg/h. Pulmonary and systemic vascular resistances (PVR and SVR) at rest were reduced by 18% (p less tha
Publikováno v:
European Journal of Clinical Pharmacology. 10:9-18
Ten asthmatic patients received an oral dose of3H-ibuterol chloride 3 mg, which upon hydrolysis generates terbutaline equivalent to 2 mg terbutaline sulphate, and3H-terbutaline sulphate 5 mg, in a double-blind, crossover study with randomized adminis
Publikováno v:
Allergy. 15:395-405
Autor:
H. Palmstierna, E. Ripe
Publikováno v:
Allergy. 17:451-457
Autor:
E Ripe, H Palmstierna
Publikováno v:
Allergy. 18:413-430
Publikováno v:
European journal of respiratory diseases. 61(2)
Colony-forming cells (CFC) and colony-forming ability in peripheral blood and bone marrow were studied in 22 patients with different stages of sarcoidosis, with or without the addition of different Kveim preparations. The study showed no statistical
Publikováno v:
European journal of respiratory diseases. 63(5)
The bronchodilating properties and side effects of theophylline and a beta 2-adrenoceptor stimulating drug (terbutaline) alone and in combination were studied in 10 adult asthmatic patients. Initially, each individual's pharmacokinetic parameters for
Publikováno v:
Lakartidningen. 72(11)